MDxHealth SA
MDXH- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001872529
In the last 90 days, MDxHealth SA insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.79M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in MDxHealth SA as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +13 vs. Q2 2024
- Shares held
- 22.8M
- +13.9M (+155.3%) vs. Q2 2024
- Total value
- $47.4M
- +$26.4M (+125.7%) vs. Q2 2024
- New holders
- 13
- 5 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.79M |
| Q1 2026 | 51 | $56.9M |
| Q4 2025 | 56 | $86.8M |
| Q3 2025 | 42 | $105.9M |
| Q2 2025 | 21 | $47.6M |
| Q1 2025 | 21 | $30.1M |
| Q4 2024 | 24 | $53.2M |
| Q3 2024 | 22 | $47.4M |
| Q2 2024 | 9 | $21.0M |
| Q1 2024 | 13 | $24.2M |
| Q4 2023 | 12 | $37.5M |
| Q3 2023 | 11 | $18.9M |
| Q2 2023 | 19 | $25.1M |
| Q1 2023 | 14 | $28.1M |
| Q4 2022 | 5 | $18.2M |
| Q3 2022 | 4 | $13.8M |
| Q2 2022 | 5 | $24.7M |
| Q1 2022 | 5 | $24.5M |
| Q4 2021 | 7 | $29.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding MDxHealth SA; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bleichroeder LP | 8,378,333 | $17.4M | 4.69% | +4,500,000+116.0% | Added |
| MVM Partners, LLC | 4,700,457 | $9.71M | 10.59% | +150,000+3.3% | Added |
| AWM Investment Company, Inc. | 4,250,000 | $8.84M | 1.07% | +4,250,000 | New |
| Soleus Capital Management, L.P. | 1,105,000 | $2.30M | 0.19% | +1,105,000 | New |
| Alyeska Investment Group, L.P. | 1,007,000 | $2.09M | 0.01% | +1,007,000 | New |
| Monashee Investment Management LLC | 1,000,000 | $2.08M | 0.23% | +1,000,000 | New |
| Samjo Management, LLC | 790,000 | $1.64M | 0.57% | +790,000 | New |
| Perkins Capital Management Inc | 747,375 | $1.55M | 1.46% | +309,500+70.7% | Added |
| Heights Capital Management, Inc | 325,000 | $676.0K | 0.50% | +325,000 | New |
| Cowen and Company, LLC | 135,090 | $281.0K | 0.01% | +135,090 | New |
| Ghisallo Capital Management LLC | 105,019 | $218.4K | 0.01% | +105,019 | New |
| Maven Securities LTD | 100,148 | $208.3K | 0.02% | +100,148 | New |
| Citadel Advisors LLC | 69,930 | $145.5K | 0.00% | +69,930 | New |
| Resources Investment Advisors, LLC. | 57,726 | $120.1K | 0.00% | +7,656+15.3% | Added |
| Financial Advisory Service, Inc. | 16,325 | $34.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,100 | $31.4K | 0.00% | +15,100 | New |
| Oppenheimer & Co Inc | 10,000 | $20.8K | 0.00% | +10,000 | New |
| Morgan Stanley | 5,483 | $11.4K | 0.00% | +350+6.8% | Added |
| UBS Group AG | 1,470 | $3.06K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,000 | $2.08K | 0.00% | +1,000 | New |
| Bank of America Corp | 755 | $1.57K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 72 | $149 | 0.00% | 00.0% | Unchanged |